Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
| behcet_disease [2026/02/04 22:40] – [Other Findings] Scott Larson | behcet_disease [2026/02/04 22:46] (current) – [Etiology] Scott Larson | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== Behçet' | ====== Behçet' | ||
| - | FIXME | + | |
| ====Main Features==== | ====Main Features==== | ||
| * Systemic Vasculitis characterized by recurrent oral ulcers (nearly all) with variable involvement of skin, eyes, joints, vascular system, GI tract and CNS | * Systemic Vasculitis characterized by recurrent oral ulcers (nearly all) with variable involvement of skin, eyes, joints, vascular system, GI tract and CNS | ||
| Line 46: | Line 46: | ||
| * Hemorrhage and/or perforation | * Hemorrhage and/or perforation | ||
| ====Etiology==== | ====Etiology==== | ||
| - | * | + | * Genetically predisposed are exposed to environmental triggers leading to activation of cellular signally pathways leading to tissue inflammation and damage. |
| + | * HLA B*51 increases the risk by 6 | ||
| + | * Highest prevalence in Turkey: 420 cases per 100,000 | ||
| + | * US: 5.2 cases per 100, | ||
| ====Resources==== | ====Resources==== | ||
| * [[https:// | * [[https:// | ||